Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München (PaMeViTUM)

This study has been terminated.
(Protocol planned interim analysis after two years showed very low recruitment in cohort 1 and low recruitment in cohort 2.)
Sponsor:
Information provided by:
Technische Universität München
ClinicalTrials.gov Identifier:
NCT00855634
First received: March 3, 2009
Last updated: September 5, 2012
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2012
  Estimated Primary Completion Date: No date given